Global Blood Therapeutics Inc. (GBT) posted a -0.38% change over the last five days signaling a new trend


Global Blood Therapeutics Inc. (NASDAQ: GBT) kicked off on September 21, 2022, at the price of $67.92, down -0.29% from the previous trading day. During the day, the shares moved up to $68.20 and dropped to $67.65 before settling in for the closing price of $67.89. Over the past 52 weeks, GBT has traded in a range of $21.65-$73.02.

Top 5 Tech Stocks Every Investor Should Buy Right Now

While finding excellent stocks with the potential for gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Tech Stocks Every Investor Should Buy Right Now", we have identified five tech stocks we believe could appreciate.

Sign up here to get your free report now.


While this was happening, its average annual earnings per share was recorded -19.30%. With a float of $62.83 million, this company’s outstanding shares have now reached $65.59 million.

The firm has a total of 457 workers. Let’s measure their productivity. In terms of profitability, gross margin is +93.87, operating margin of -147.72, and the pretax margin is -155.39.

Global Blood Therapeutics Inc. (GBT) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The most recent insider transaction that took place on Sep 01, was worth 2,137,988. In this transaction Chief Financial Officer of this company sold 31,441 shares at a rate of $68.00, taking the stock ownership to the 3,086 shares. Before that another transaction happened on Aug 18, when Company’s insider sold 4,678 for $67.19, making the entire transaction worth $314,315. This insider now owns 8,918 shares in total.

Global Blood Therapeutics Inc. (GBT) Recent Fiscal highlights

In the latest quarterly report, which was put into the public domain on 3/30/2022, the organization reported -$1.26 earnings per share (EPS), higher than consensus estimate (set at -$1.3) by $0.04. This company achieved a net margin of -155.63 while generating a return on equity of -98.96. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.1 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -19.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.00% during the next five years compared to -14.20% drop over the previous five years of trading.

Global Blood Therapeutics Inc. (NASDAQ: GBT) Trading Performance Indicators

Take a look at Global Blood Therapeutics Inc.’s (GBT) current performance indicators. Last quarter, stock had a quick ratio of 6.20. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.49.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.00, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -2.82 in one year’s time.

Technical Analysis of Global Blood Therapeutics Inc. (GBT)

Analysing the last 5-days average volume posted by the [Global Blood Therapeutics Inc., GBT], we can find that recorded value of 3.32 million was better than the volume posted last year of 2.05 million. As of the previous 9 days, the stock’s Stochastic %D was 58.73%. Additionally, its Average True Range was 0.34.

During the past 100 days, Global Blood Therapeutics Inc.’s (GBT) raw stochastic average was set at 89.62%, which indicates a significant increase from 22.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.83% in the past 14 days, which was lower than the 87.76% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $56.32, while its 200-day Moving Average is $36.42. Now, the first resistance to watch is $68.04. This is followed by the second major resistance level at $68.40. The third major resistance level sits at $68.59. If the price goes on to break the first support level at $67.49, it is likely to go to the next support level at $67.30. Now, if the price goes above the second support level, the third support stands at $66.94.

Global Blood Therapeutics Inc. (NASDAQ: GBT) Key Stats

The company with the Market Capitalisation of 4.58 billion has total of 67,476K Shares Outstanding. Its annual sales at the moment are 194,750 K in contrast with the sum of -303,090 K annual income. Company’s last quarter sales were recorded 71,550 K and last quarter income was -82,470 K.


Please enter your comment!
Please enter your name here